Moderna (MRNA) PT Lowered to $140 at JPMorgan
Tweet
Share
E-mailGet Alerts MRNA Hot Sheet
Price: $158.83 --0%
Rating Summary:
6 Buy, 22 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 13 | New: 9
Rating Summary:
6 Buy, 22 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 13 | New: 9
Join SI Premium – FREE
JPMorgan analyst Jessica Fye lowered the price target on Moderna (NASDAQ: MRNA) to $140.00 (from $145.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Wolfe Research Upgrades Moderna (MRNA) to Peerperform
- Citi Downgrades China COSCO Holdings (1919:HK) (CICOY) to Neutral
- Moderna (MRNA) call put ratio 1.1 calls to 1 put amid sharp rally
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
